New Concepts in Androgen Deprivation Therapy (ADT) Agonists vs. Antagonists and All the Rest- Tom Keane

February 8, 2017

Thomas Keane's video lecture is a state of the art review of personalized androgen deprivation therapy (ADT) for men being treated for advanced prostate cancer.   This discussion includes the most recent data and considerations relative to identifying patients with cardiovascular disease, obesity and testosterone, fatty acid synthase (FSH) and adipogenous, high volume metastatic disease, use of docetaxel before or after ADT and clinical implications for patient outcomes.  

Additonal reading from Thomas Keane on ADT:
Considerations in the use of Androgen Deprivation Therapy for the Treatment of Men with Advanced Prostate Cancer